<unk>  is an antineoplastic and a mitotic inhibitor that is FDA approved for the treatment of childhood acute lymphoblastic leukemia.   Common adverse reactions include diarrhea, inflammatory disease of mucous membrane, nausea, vomiting, anemia, leukopenia, thrombocytopenia and infectious disease.
Teniposide
Sincalide
Deslanoside
Pegloticase
Hydroxyethyl starch
Tiamulin
Alglucosidase alfa
Thiocolchicoside